Eli Lilly stock gains after obesity drug data at conference
Eli Lilly stock gains after obesity drug data at conference
Eli Lilly stock gains after obesity drug data at conference
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.